n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cardiac Hypertrophy in 4 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, H | 1 |
Gao, S | 2 |
Ye, J | 1 |
Feng, X | 1 |
Cai, Y | 1 |
Liu, Z | 1 |
Lu, J | 1 |
Li, Q | 1 |
Huang, X | 1 |
Chen, S | 1 |
Liu, P | 1 |
Park, BM | 1 |
Cha, SA | 1 |
Kim, SH | 1 |
LaPointe, MC | 1 |
Mendez, M | 1 |
Leung, A | 1 |
Tao, Z | 1 |
Yang, XP | 1 |
Vanecková, I | 1 |
Skaroupková, P | 1 |
Dvorák, P | 1 |
Certíková Chábová, V | 1 |
Tesar, V | 1 |
Bader, M | 1 |
Ganten, D | 1 |
Kramer, HJ | 1 |
4 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cardiac Hypertrophy
Article | Year |
---|---|
COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Topics: Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 | 2014 |
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cyclo | 2015 |
Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
Topics: Animals; Cardiomegaly; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhib | 2004 |
Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats.
Topics: Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Cardiomegaly; Cyclooxygenase In | 2005 |